Difference between revisions of "Part:BBa K4586009"
Ahmed Mattar (Talk | contribs) (→Usage) |
Ahmed Mattar (Talk | contribs) |
||
Line 22: | Line 22: | ||
lang=EN style='font-size:11.0pt;line-height:115%'>Figure 1: This figure illustrates the construction of our engineered exosomes that express citrullinated vimentin on their membranes conjugated to a transmembrane protein known as lysosome-associated membrane glycoprotein 2b (lamp2b), which is unique to the membrane of exosomes. | lang=EN style='font-size:11.0pt;line-height:115%'>Figure 1: This figure illustrates the construction of our engineered exosomes that express citrullinated vimentin on their membranes conjugated to a transmembrane protein known as lysosome-associated membrane glycoprotein 2b (lamp2b), which is unique to the membrane of exosomes. | ||
</span></p></div></html> | </span></p></div></html> | ||
+ | ==Literature Characterization== | ||
+ | The study used X-Gal staining of brain sections from double transgenic mice to show the effect of active Notch1 signaling in mice. The results suggest that the activation of the N1-Gal4VP16 reporter is consistent with the activity of the endogenous Notch1 receptor. This reporter mouse is a powerful tool for visualizing active Notch1 signaling in embryonic and post-natal development in vivo. | ||
+ | <html><div align="center"style="border:solid #17252A; width:50%;float:center;"><img style=" max-width:850px; | ||
+ | width:75%; | ||
+ | height:auto; | ||
+ | position: relative; | ||
+ | top: 50%; | ||
+ | left: 35%; | ||
+ | transform: translate( -50%); | ||
+ | padding-bottom:25px; | ||
+ | padding-top:25px; | ||
+ | "src="https://static.igem.wiki/teams/4586/wiki/literature-characterisation-parts/lamp2b.png"> | ||
+ | <p class=MsoNormal align=center style='text-align:left;border:none;width:98% ;justify-content:center;'><span | ||
+ | lang=EN style='font-size:11.0pt;line-height:115%'>To confirm that iRGD-Lamp2b was successfully transfected into the imDCs, the amounts of iRGD-Lamp2b mRNA was measured 36 hours after transfection using RT-PCR.The results showed that the transfected imDCs expressed high levels of iRGD-Lamp2b mRNA, compared to the untransfected imDCs. This confirmed that the transfected imDCs were producing iRGD-positive exosomes. | ||
+ | </span></p></div></html> | ||
+ | |||
+ | ==References== | ||
+ | Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G. J., ... & Nie, G. (2014). A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials, 35(7), 2383-2390. | ||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
===Usage and Biology=== | ===Usage and Biology=== |
Revision as of 15:45, 24 September 2023
lamp2b
Part Description
This part is the gene coding for a member of a family of membrane glycoproteins called Lysosome-associated membrane protein 2 (LAMP2), through modification of the outer membrane domain of the lamp2b. Our target protein can be delivered to the exosome's surface using Lamp 2b.
Usage
This part is used to express citrullinated vimentin on the exosomal surface to increase the exosomes' affinity for the autoreactive B-cells, as this transmembrane protein is unique to the membrane of exosomes and lysosomes, so the likelihood of exosome and B-cell fusion has significantly increased as shown in figure 1.
Figure 1: This figure illustrates the construction of our engineered exosomes that express citrullinated vimentin on their membranes conjugated to a transmembrane protein known as lysosome-associated membrane glycoprotein 2b (lamp2b), which is unique to the membrane of exosomes.
Literature Characterization
The study used X-Gal staining of brain sections from double transgenic mice to show the effect of active Notch1 signaling in mice. The results suggest that the activation of the N1-Gal4VP16 reporter is consistent with the activity of the endogenous Notch1 receptor. This reporter mouse is a powerful tool for visualizing active Notch1 signaling in embryonic and post-natal development in vivo.
To confirm that iRGD-Lamp2b was successfully transfected into the imDCs, the amounts of iRGD-Lamp2b mRNA was measured 36 hours after transfection using RT-PCR.The results showed that the transfected imDCs expressed high levels of iRGD-Lamp2b mRNA, compared to the untransfected imDCs. This confirmed that the transfected imDCs were producing iRGD-positive exosomes.
References
Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G. J., ... & Nie, G. (2014). A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials, 35(7), 2383-2390. Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]